We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Executive summary of quality assurance visit to Colchester Hospital University NHS Foundation Trust held on 15 September 2016.
Professor John Deanfield, CBE announced as the first ever Government Champion for Personalised Prevention.
First published during the 2022 to 2024 Sunak Conservative government
Medical guidance for DWP staff who make decisions on child cases for Disability Living Allowance (DLA).
People are urged to use the updated tool to find out their heart age and their risk of heart attack and stroke this World Heart Day.
Carefully consider the benefits and risks before prescribing systemic azithromycin or other systemic macrolide antibiotics (erythromycin or clarithromycin) to patients being treated with hydroxychloroquine or chloroquine. An observational study in patients with rheumatoid arthritis has shown that co-administration of azithromycin...
Tofacitinib should not be used in patients older than 65 years of age, people who are current or past smokers, or individuals with other cardiovascular (such as diabetes or coronary artery disease) or malignancy risk factors unless there are no...
A brand-new challenge for artificial intelligence and machine learning developers, to build models that can predict heart failure-related health outcomes for veterans has been launched by a collaboration between regulators and healthcare organisations in the UK and US.
Public Health England is urging the public to find out their ‘heart age’, with 50 preventable deaths from heart attack or stroke happening every day.
These profiles aim to help the NHS and local authorities understand more about these conditions in their communities.
We inform healthcare professionals of new risk minimisation measures for JAK inhibitors used to treat chronic inflammatory disorders, consistent with the measures introduced for tofacitinib (Xeljanz) in 2020 and 2021. This advice affects abrocitinib (Cibinqo▼), baricitinib (Olumiant), upadacitinib (Rinvoq▼), and...
Caution is required if prescribing febuxostat in patients with pre-existing major cardiovascular disease, particularly, in those with evidence of high urate crystal and tophi burden or those initiating urate-lowering therapy.
Erythromycin has been associated with events secondary to QT interval prolongation such as cardiac arrest and ventricular fibrillation. Erythromycin should not be given to patients with a history of QT interval prolongation or ventricular cardiac arrhythmia, including torsades de pointes,...
Risk minimisation materials are available to support the safe use of new paediatric formulations of rivaroxaban (Xarelto) and dabigatran etexilate (Pradaxa). In addition, we ask healthcare professionals to consult the current advice to ensure that all patients with renal impairment...
New Better Health campaign offers free support and guidance to those working towards a healthier weight.
First published during the 2019 to 2022 Johnson Conservative government
Fluoroquinolones should only be used after careful benefit-risk assessment and after consideration of other therapeutic options in patients at risk for heart valve regurgitation (incompetence).
Modafinil potentially increases the risk of congenital malformations when used in pregnancy. Modafinil should not be used during pregnancy and women of childbearing potential must use effective contraception during treatment and for 2 months after stopping modafinil.
Public Health England and NHS England lead coalition of over 40 organisations to step up fight against the nation’s biggest killer.
Ground-breaking innovation to support medical technologies
PHE campaign urges people to see a GP if they have breathlessness or a persistent cough, as these are symptoms of these diseases.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).